Drug intelligence / Profile preview

Amphiron Deep

Development stage
Unknown
Lead developer
Lutonix
Modality
Small Molecules
Administration
Topical
01

Overview

Amphiron Deep is a specialized topical lipid-based formulation of amphotericin B, a polyene antifungal and antiprotozoal agent. Developed by Bharat Serums and Vaccines, it is primarily indicated for the treatment of cutaneous leishmaniasis, a parasitic disease caused by *Leishmania* species. The "Deep" formulation is engineered to enhance the transdermal penetration of the large amphotericin B molecule, allowing it to reach the deeper layers of the dermis where the parasites reside within macrophages. Mechanistically, amphotericin B binds to ergosterol in the cell membranes of fungi and *Leishmania* promastigotes and amastigotes, leading to the formation of aqueous pores. These pores cause the leakage of essential intracellular ions, such as potassium, resulting in cell lysis and death. This topical delivery system aims to provide high local drug concentrations while significantly reducing the risk of nephrotoxicity and other systemic side effects associated with parenteral amphotericin B administration.

Brand names
Amphiron Deep
Other names
Amphotericin B topical emulsionAmphotericin B topical gel
02

Targets

Ergosterol

Beyond the preview

Go deeper on Amphiron Deep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amphiron Deep.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call